The development of therapeutics for ALS/MND is largely based on work in experimental animals carrying human SOD mutations. However, translation of apparent therapeutic successes from in vivo to the human disease has proven difficult and a considerable amount of financial resources has been apparently wasted. Standard operating procedures (SOPs) for preclinical animal research in ALS/MND are urgently required. Such SOPs will help to establish SOPs for translational research for other neurological diseases within the next few years. To identify the challenges and to improve the research methodology, the European ALS/MND group held a meeting in 2006 and published guidelines in 2007 (1). A second international conference to improve the guidelines was held in 2009. These second and improved guidelines are dedicated to the memory of Sean F. Scott.

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

CHIO', Adriano;
2010-01-01

Abstract

The development of therapeutics for ALS/MND is largely based on work in experimental animals carrying human SOD mutations. However, translation of apparent therapeutic successes from in vivo to the human disease has proven difficult and a considerable amount of financial resources has been apparently wasted. Standard operating procedures (SOPs) for preclinical animal research in ALS/MND are urgently required. Such SOPs will help to establish SOPs for translational research for other neurological diseases within the next few years. To identify the challenges and to improve the research methodology, the European ALS/MND group held a meeting in 2006 and published guidelines in 2007 (1). A second international conference to improve the guidelines was held in 2009. These second and improved guidelines are dedicated to the memory of Sean F. Scott.
2010
11
38
45
Ludolph AC; Bendotti C; Blaugrund E; Chiò A; Greensmith L; Loeffler JP; Mead R; Niessen HG; Petri S; Pradat PF; Robberecht W; Ruegg M; Schwalenstöcker B; Stiller D; van den Berg L; Vieira F; von Horsten S.
File in questo prodotto:
File Dimensione Formato  
ALS 2010 - Ludolph - preclinical guidelines.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 118.95 kB
Formato Adobe PDF
118.95 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/74255
Citazioni
  • ???jsp.display-item.citation.pmc??? 118
  • Scopus 260
  • ???jsp.display-item.citation.isi??? 246
social impact